Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia
Palabras clave :
BCR/ABL tyrosine kinase inhibitor
Bosutinib
Ponatinib
Imatinib
Nilotinib
Dasatinib
Chronic myeloid leukemia
Pharmacology
Fecha de publicación :
2018
Nota:
This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Cita:
Azanza, J.R. (José Ramón); Sadaba, B. (Belén); Díez, N. (Nieves). "Comparative pharmacology of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia". International journal of clinical pharmacology & pharmacotherapy. 3 (134), 2018,
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.